ARTICLES BY PHILIP CARRIGAN

• It’s Time For Market Access To Play A Leading Role In Pharma

  5/1/2016

  Escalating healthcare costs due to the growing numbers of patients with chronic diseases, the aging population, and higher prices of new therapies mean companies urgently need to bolster their Market Access functions.

• Biosimilars Are the New Black

  3/4/2016

  Biologics have taken the pharma world by storm over the past decade or so. Five of the top 10 best-selling drugs in 2014, for example, were biologics indicated for either autoimmune disorders or cancer. Biosimilars, by the nature of their development process, cannot be exact replicas of approved biological drugs. This issue has left considerable room for pharmaceutical companies to defend their star products in the patent arena.

• Don't Accept The Job Offer

  2/10/2016

  Asking a recruiter if a candidate should accept a job offer is a lot like asking a barber if you need a haircut. The answer is “Yes”. When should a candidate reject the offer? What are the red flags?

• Technology Provides Opportunities for Medical Device Companies

  2/5/2016

  Will 2016 be the year that medical device companies cash in and navigate terrains that are increasingly integrated with new technology?

• Take Charge Of Your Pharma Career — It’s Your Choice

  12/10/2015

  Most people are optimistic about the future of their company, but we still need to plan for change. Our past careers are a mix of good and bad. It is human nature to overestimate the brightness of our futures.

• Recruiternomics

  10/15/2015

  How are recruiting fees determined? Why do candidates reject offers when (from a logical standpoint) the decision doesn’t appear to make sense? How does opportunity cost factor into the recruiting process, and how do recruiters allocate resources? Behavioral economic analysis offers some psychological insights into the economic decision making of recruiters and candidates.

• Pharma Companies In JPAC Are Searching For The Goldilocks Candidate

  10/15/2015

  I sat and listened to the Japan and Asia Pacific (JPAC) Vice President describe the ideal candidate that she was looking for as a Regional Medical Affairs Director of an American Pharmaceutical company.